All Stories

  1. Contribution of maternal and fetal genetics to fetal weight throughout pregnancy and at birth
  2. Maternal immune gene expression trajectories and dynamic genetic regulation throughout pregnancy
  3. Prospective cohort study of unselected nulliparous women with a nested randomised controlled trial of screening using the sFLT1:PlGF ratio, ultrasound and maternal characteristics and intervention using enhanced monitoring and early delivery: study pro...
  4. A prospective cohort study of unselected nulliparous women with a nested randomized controlled trial of screening using the sFLT1:PlGF ratio, ultrasound and maternal characteristics and intervention using enhanced monitoring and early delivery: study p...
  5. Towards microbiome-informed strategies for predicting and preventing pregnancy complications
  6. Deciphering Roles of Placental Endoplasmic Reticulum Stress in Complicated Pregnancies and Beyond: The Power of Mouse Models
  7. The human placenta and its role in reproductive outcomes revisited
  8. Raised Leptin and Pappalysin2 cell-free RNAs are the hallmarks of pregnancies complicated by preeclampsia with fetal growth restriction
  9. Genetic Variants Associated With Preeclampsia and Maternal Serum sFLT1 Levels
  10. Single-cell RNA sequencing identifies CXADR as a fate determinant of the placental exchange surface
  11. GDF15 linked to maternal risk of nausea and vomiting during pregnancy
  12. Longitudinal profiling of the pregnancy plasma proteome through organic solvent precipitation and nano LC-MS/MS
  13. Placental Streptococcus agalactiae DNA is associated with neonatal unit admission and foetal pro-inflammatory cytokines in term infants
  14. Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study
  15. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study
  16. Objective measures of smoking and caffeine intake and the risk of adverse pregnancy outcomes
  17. Protocol for culturing the endocrine junctional zone of the mouse placenta in serum-free medium
  18. Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth
  19. The human placenta exhibits a unique transcriptomic void
  20. Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy
  21. Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor
  22. Physiologically relevant culture medium Plasmax improves human placental trophoblast stem cell function
  23. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction
  24. Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism
  25. The human placenta exhibits a unique transcriptomic void
  26. Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress
  27. Placental sex-dependent spermine synthesis regulates trophoblast gene expression through acetyl-coA metabolism and histone acetylation
  28. Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus
  29. Author Correction: Inherent mosaicism and extensive mutation of human placentas
  30. Erratum to: A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  31. Placental energy metabolism in health and disease—significance of development and implications for preeclampsia
  32. A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  33. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
  34. Placental polyamines regulate acetyl-coA and histone acetylation in a sex-specific manner
  35. RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first–second trimester transition
  36. Inherent Mosaicism and Extensive Mutation of Human Placentas
  37. The RNA landscape of the human placenta in health and disease
  38. Inherent mosaicism and extensive mutation of human placentas
  39. Somatic mutations reveal widespread mosaicism and mutagenesis in human placentas
  40. Batch effects account for the main findings of an in utero human intestinal bacterial colonization study
  41. Abnormal placental CD8 + T‐cell infiltration is a feature of fetal growth restriction and pre‐eclampsia
  42. Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa
  43. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia
  44. A high-throughput platform for detailed lipidomic analysis of a range of mouse and human tissues
  45. A maternal serum metabolite ratio predicts fetal growth restriction at term
  46. P112 Activation of PIK3CA in a model of endometriosis may shed light on the pathogenesis of ovarian clear cell adenocarcinoma
  47. Author Correction: Human placenta has no microbiome but can contain potential pathogens
  48. IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery
  49. Role of soluble endoglin in BMP9 signaling
  50. Three-dimensional morphological analysis of placental terminal villi
  51. Human placenta has no microbiome but can contain potential pathogens
  52. The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities
  53. The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome
  54. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia
  55. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide
  56. A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
  57. 440: Low cortisol to cortisone ratio precedes pre-eclampsia (PE) and fetal growth restriction (FGR)
  58. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  59. Correction to: Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  60. Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  61. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
  62. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
  63. Recognizing the reagent microbiome
  64. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  65. Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
  66. Estimating neonatal length of stay for babies born very preterm
  67. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  68. Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys
  69. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers
  70. Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women
  71. Age at menarche and the risk of operative delivery
  72. RNA-Seq reveals conservation of function among the yolk sacs of human, mouse and chicken
  73. RNA-seq reveals conservation of function among the yolk sacs of human, mouse, and chicken
  74. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor RatioNovelty and Significance
  75. 155: Screening for late fetal growth restriction using ultrasound and the sFlt-1:PlGF ratio
  76. Computational modeling of the structure-function relationship in human placental terminal villi
  77. Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction
  78. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes
  79. Three-dimensional modeling of human placental terminal villi
  80. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
  81. The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth
  82. Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications
  83. Leptin Matures Aspects of Lung Structure and Function in the Ovine Fetus
  84. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma
  85. Age‐related changes in murine myometrial transcript profile are mediated by exposure to the female sex hormones
  86. The Effect of an Oxytocin Receptor Antagonist (Retosiban, GSK221149A) on the Response of Human Myometrial Explants to Prolonged Mechanical Stretch
  87. Morphological and molecular changes in the murine placenta exposed to normobaric hypoxia throughout pregnancy
  88. Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung
  89. The acute-phase protein SAA3 is present in the preterm human colostrum and breast milk
  90. Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development
  91. Endoplasmic reticulum stress regulates placental growth factor expression in human choriocarcioma cells
  92. 3D surface reconstruction of human terminal villi and the fetal capillary bed
  93. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early‐ and late‐onset pre‐eclampsia
  94. Influence of speed of sample processing on placental energetics and signalling pathways: Implications for tissue collection
  95. Phosphorylation changes in survival and stress-response signalling pathways in the human placenta as an artefact of delayed tissue collection
  96. Redefining Preeclampsia Using Placenta-Derived Biomarkers
  97. Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis
  98. Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction
  99. Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility
  100. Proceedings of Research in Clinical Practice 2011
  101. A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
  102. Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A–1
  103. Gene network inference and visualization tools for biologists: application to new human transcriptome datasets
  104. Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice
  105. Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?
  106. Functional analysis of the antioxidant paraoxonase-3 in lung epithelial cells by rna interference
  107. Dynamic expression and steroid regulation of sarg, a novel gene in the perinatal lung
  108. Estimating Genome-Wide Gene Networks Using Nonparametric Bayesian Network Models on Massively Parallel Computers
  109. Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis
  110. Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner
  111. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo
  112. MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms
  113. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling
  114. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  115. VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes
  116. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
  117. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  118. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  119. Paraoxonase-3, a Putative Circulating Antioxidant, Is Systemically Up-Regulated in Late Gestation in the Fetal Rat, Sheep, and Human
  120. VEGF-A and Serum Withdrawal Induced Changes in the Transcript Profile in Human Endometrial Endothelial Cells
  121. Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4
  122. The influence of the intrauterine environment on human placental development
  123. Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium
  124. Regulation of vascular growth and function in the human placenta
  125. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys
  126. Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cells
  127. Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia
  128. Characterization of Serotonin Receptors in Pregnant Human Myometrium
  129. Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study
  130. UNRAVELING DYNAMIC ACTIVITIES OF AUTOCRINE PATHWAYS THAT CONTROL DRUG-RESPONSE TRANSCRIPTOME NETWORKS
  131. Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment
  132. Evidence of Placental Translation Inhibition and Endoplasmic Reticulum Stress in the Etiology of Human Intrauterine Growth Restriction
  133. Transcript profile and localization of Wnt signaling–related molecules in human endometrium
  134. The Effect of Delaying Childbirth on Primary Cesarean Section Rates
  135. Stimulation of Contractions in Human Myometrium by Serotonin is Unmasked by Smooth Muscle Relaxants
  136. Statistical inference of transcriptional module-based gene networks from time course gene expression profiles by using state space models
  137. Localization and Control of Expression of VEGF-A and the VEGFR-2 Receptor in Fetal Sheep Intestines
  138. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration
  139. 325: Maternal age and uterine function: A biological basis for rising rates of cesarean delivery
  140. Oxidative Stress, Gene Expression, and Protein Changes Induced in the Human Placenta during Labor
  141. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?
  142. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium
  143. Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment
  144. Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta)
  145. Nuclear Factor-κB, p38, and Stress-Activated Protein Kinase Mitogen-Activated Protein Kinase Signaling Pathways Regulate Proinflammatory Cytokines and Apoptosis in Human Placental Explants in Response to Oxidative Stress
  146. Human Early Placental Development: Potential Roles of the Endometrial Glands
  147. Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization
  148. Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells
  149. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2
  150. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia
  151. In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer
  152. Changes in Gene Expression during Wolffian Duct Development
  153. Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT
  154. COMPUTATIONAL STRATEGY FOR DISCOVERING DRUGGABLE GENE NETWORKS FROM GENOME-WIDE RNA EXPRESSION PROFILES
  155. Reply: Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in human endometrial tissues?
  156. Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception
  157. Vascular growth and modelling in the endometrium
  158. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys
  159. Novel antiangiogenic agents for use in contraception
  160. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
  161. 126. Progesterone regulates CXCL14 (macrophage inflammatory protein 2γ) mRNA in human endometrium
  162. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma
  163. Independent component analysis of microarray data in the study of endometrial cancer
  164. Secretion of Tumor Necrosis Factor-α from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro
  165. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. I. Molecular Regulation
  166. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. II. Changes During Normal Pregnancy
  167. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. III. Changes in Complicated Pregnancies
  168. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF
  169. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  170. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation
  171. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  172. The effect of RU486 on the gene expression profile in an endometrial explant model
  173. Antiangiogenic Agents Are Effective Inhibitors of Endometriosis
  174. Intralobular Differences in Antioxidant Enzyme Expression and Activity Reflect the Pattern of Maternal Arterial Bloodflow Within the Human Placenta
  175. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor ☆☆This study was supported by grants from the Heart and Stroke Foundation of Ontario (T-3361) and the Canadian Institutes of Health Research (MT-1502...
  176. Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17β-Estradiol in the Mouse Uterus
  177. Identification of Genes with Differential Regulation in Primate Endometrium During the Proliferative and Secretory Phases of the Cycle
  178. Generation and use of a tailored gene array to investigate vascular biology
  179. Determination of the transcript profile of human endometrium
  180. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
  181. vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages
  182. Placental Vessel Adaptation During Gestation and to High Altitude: Changes in Diameter and Perivascular Cell Coverage
  183. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle
  184. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function
  185. Is estradiol cardioprotection a nitric oxide-mediated effect?
  186. A longitudinal study of biochemical variables in women at risk of preeclampsia
  187. Hypoxia-Reoxygenation
  188. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature*
  189. Soluble flt and the angiopoietins in the development and regulation of placental vasculature
  190. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
  191. Large scale analysis of transcripts in human endometrium
  192. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  193. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  194. The Regulation and Localization of Angiopoietin-1, -2, and Their Receptor Tie2 in Normal and Pathologic Human Placentae
  195. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
  196. Angiogenesis and Blood Flow: Implications for Pathobiology—A Workshop Report
  197. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells
  198. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1
  199. Placental Vascular Morphogenesis: Introduction and Overview
  200. Placental vascular morphogenesis
  201. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey
  202. Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays
  203. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
  204. Angiogenic growth factor expression in placenta
  205. Angiogenesis in reproduction
  206. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia1
  207. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia
  208. The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium
  209. Alternative Splicing of Vascular Endothelial Growth Factor (VEGF)-R1 (FLT-1) pre-mRNA Is Important for the Regulation of VEGF Activity
  210. Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy1
  211. A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1
  212. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
  213. Placental angiogenesis: the role of the VEGF family of proteins
  214. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies
  215. Expression and Localization of the Th2-type Cytokine Interleukin-13 and Its Receptor in the Placenta During Human Pregnancy
  216. The role of leukaemia inhibitory factor and interleukin-6 in human reproduction
  217. Vascular endothelial growth factor and corpus luteum angiogenesis
  218. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies
  219. VEGF mRNA Levels in Placentae From Pregnancies Complicated by Pre-Eclampsia
  220. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis
  221. Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production
  222. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
  223. In-vivo gene transfer to the uterine endometrium
  224. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis
  225. PGE2 and TXA2 Production by Isolated Macrophages from Human Placenta
  226. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  227. Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy
  228. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia
  229. Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour
  230. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum
  231. Vascular Endothelial Growth Factor (VEGF) Concentrations Are Elevated in Peritoneal Fluid of Women With Endometriosis
  232. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
  233. Expression of interleukin-13 by first trimester human villous trophoblast
  234. Hepatocyte growth factor and its receptor c-met: Localization and expression in the human placenta
  235. Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy
  236. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
  237. Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha)
  238. Expression of prostacyclin and thromboxane synthases in placenta and placental bed after pre-eclamptic pregnancies
  239. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
  240. Stage-Specific Expression of Cytokine and Receptor Messenger Ribonucleic Acids in Human Preimplantation Embryos1
  241. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
  242. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata
  243. Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  244. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
  245. Quantification of mRNA in Human Tissue Using Fluorescent Nested Reverse-Transcriptase Polymerase Chain Reaction
  246. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
  247. Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction
  248. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
  249. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction
  250. Capture PCR: An Efficient Method for Walking Along Chromosomal DNA and cDNA
  251. Expression of mRNA for vascular endothelial growth factor in human placenta
  252. Alternatively Spliced mRNAs for Human Endothelin-2 and Their Tissue Distribution
  253. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
  254. Endothelin-2 mRNA Splice Variants Detected by RT-PCP in Cultured Human Vascular Smooth Muscle and Endothelial Cells
  255. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
  256. [91] Fluorescent and radioactive solid-phase dideoxy sequencing of polymerase chain reaction products in microtiter plates
  257. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.
  258. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle
  259. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants
  260. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants.
  261. New protocols for DNA sequencing with dye terminators
  262. Evidence against a role for blastocyst-secreted oxytocin in early pregnancy maintenance in sheep
  263. Identification of mRNA for epidermal growth factor and transforming growth factor-α present in low copy number in human endometrium and decidua using reverse transcriptase-polymerase chain reaction
  264. Cloning and characterization of a gene encoding pig epidermal growth factor
  265. Fluorescent and radioactive solid phase dideoxy sequencing of per products in microtitre plates
  266. PCR walking from microdissection clone M54 identifies three exons from the human gene for the neural cell adhesion molecule L1 (CAM-L1)
  267. Luteal oxytocin: characteristics and control of synchronous episodes of oxytocin and PGF2α secretion at luteolysis in ruminants
  268. Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction
  269. A rapid semi-automated microtiter plate method for analysis and sequencing by PCR from bacterial stocks
  270. Nucleotide sequence of a full length cDNA clone encoding the oxytocin-neurophysin I precursor isolated from the ovine corpus luteum
  271. Concentrations of oxytocin-neurophysin prohormone mRNA in corpora lutea of sheep during the oestrous cycle and in early pregnancy
  272. The contribution of recombinant DNA techniques to reproductive biology
  273. Does the human corpus luteum synthesize neurohypophysial hormones?
  274. Linear Amplification Sequencing with Dye Terminators
  275. Working with Oxygen and Oxidative Stress In Vitro
  276. Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction